Draft Shows User Fees Likely To Be Reauthorized As Negotiated Despite Calls For Changes From Trump

Despite President Donald Trump's calls to reopen user fee agreements, congressional leaders on both side of the aisle are moving forward with authorizing the terms agreed upon earlier this year by industry and FDA, according to a discussion draft of the re-authorization legislation released Friday (April 14). However, it appears that one key Republican is already pushing to tack on riders to the agreement, and the discussion draft includes reauthorization of a number of other programs not mentioned in the...